Nancy Dvorin

Managing Editor

20 Years of Experience

About

@NancyDvorin has been covering and analyzing the medical device and pharmaceutical industries for more than 20 years. Prior to joining MedTech Strategist, she was the managing editor of several life sciences business publications including In Vivo and Medtech Insight. Earlier in her career, Nancy managed library and information services for a number of multinational corporations.

Articles from Nancy Dvorin:

Perspective & Commentary

Digital Edition: Market Pathways April-May 2025

How EBR Systems navigated the COVID pandemic and recent CDRH layoffs in its quest to gain FDA approval for its heart failure device. Building a methodological framework to align clinical expectations with different device types in MDR/IVDR; Tips for dealing with the DOGE-era FDA, plus the latest on people and functions lost at CDRH; and a look at the new European Health Data Space Regulation.

Read Article